700 patients110,866 observations180 daysLIVE

Patient P-02518

Synthetic patientMETA-24 · Day 171 · 25–34 · M · baseline S17Open companion preview
Therapy response
Favorable
Tolerance
Favorable
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Favorable
Discontinuation risk
14%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S17
  2. Day 13 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 32 DT-01 recommendedDosing / Timing Recommendation DT-01
  4. Day 33 Patient acceptedStarted DT-01 in the companion
  5. Day 38 GI symptom burden −11% vs expectedDosing / Timing Recommendation DT-01
  6. Day 44 Tolerance state changedUnstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 13.

Primary contributors, last 14 days
  • Inflammatory activity-10
  • GI instability-9
  • Nutritional resilience+4
  • Toxicity-2

What helped?

  • Dosing / Timing Recommendation DT-01Day 32
    Result: symptom burden −11%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients.

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Autonomic recovery 20
    • Wearable3,969 steps/day
  • Inflammatory signalling 15
    • WearableHRV 33 ms, trending down
DNA
Fictional pharmacogenomic panel
  • CYP2D6 Intermediate metabolizer
    Expected exposure
  • MTHFR C677T
    Reduced folate turnover
Microbiome
Shannon diversity 4 · butyrate capacity 49/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisNormal
  • Bifidobacterium longumLow
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
34 ms
Sleep
6.3 h
Steps
4,632
Resting HR
72 bpm
Daily log: GI score 18, nutritional resilience 65, adherence 92.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Keep fibre steady; no new sources this week
  • Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
  • Log the daily check-in; one line is enough
  • A 15-minute walk after lunch
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the dose at the same time relative to your evening meal
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0260456%S0367
P-0219455%S0367
P-0210953%S0466
P-0233851%S1757
P-0247551%S1159
P-0209549%S0866
P-0209749%S1762
P-0221049%S1464
P-0226649%S0365
P-0235749%S1361
P-0256949%S1561
P-0233348%S2061